ExploreWatchlistsPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Total liabilities

Sumitomo Pharma Co., Ltd. (4506)

Market cap
¥877B
P/E ratio
9.5x
Sumitomo Pharma manufactures and sells prescription pharmaceuticals globally, with specialized focus on regenerative and cell medicine through joint ventures.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 2025573,125-23.72%
Mar 31, 2024751,370+3.22%
Mar 31, 2023727,960+14.74%
Mar 31, 2022634,438-3.87%
Mar 31, 2021659,949+6.31%
Mar 31, 2020620,773+84.44%
Mar 31, 2019336,579-5.71%
Mar 31, 2018356,961+7.10%
Mar 31, 2017333,293+27.58%
Mar 31, 2016261,242+0.26%
Mar 31, 2015260,562

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat